Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam, The Netherlands
Department of Laboratory Medicine, Endocrine Laboratory, Amsterdam UMC location University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands
Search for other papers by Heleen I Jansen in
Google Scholar
PubMed
Department of Computer Science, Vrije Universiteit, Boelelaan, Amsterdam, The Netherlands
Search for other papers by Marije van Haeringen in
Google Scholar
PubMed
Search for other papers by Marelle J Bouva in
Google Scholar
PubMed
Amsterdam Public Health, Amsterdam, The Netherlands
Search for other papers by Wendy P J den Elzen in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Amsterdam UMC location University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands
Search for other papers by Eveline Bruinstroop in
Google Scholar
PubMed
Search for other papers by Catharina P B van der Ploeg in
Google Scholar
PubMed
Department of Paediatric Endocrinology, Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
Department of Paediatric Endocrinology, Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands
Search for other papers by Nitash Zwaveling-Soonawala in
Google Scholar
PubMed
Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam, The Netherlands
Department of Laboratory Medicine, Endocrine Laboratory, Amsterdam UMC location University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
Department of Pediatrics, Division of Metabolic Disorders, Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands
Search for other papers by Annet M Bosch in
Google Scholar
PubMed
Department of Laboratory Medicine, Amsterdam UMC, Vrije Universiteit, Boelelaan, Amsterdam, The Netherlands
Department of Laboratory Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands
Search for other papers by Robert de Jonge in
Google Scholar
PubMed
Search for other papers by Mark Hoogendoorn in
Google Scholar
PubMed
Department of Laboratory Medicine, Endocrine Laboratory, Amsterdam UMC location University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Anita Boelen in
Google Scholar
PubMed
) concentration in combination with an increased thyroid-stimulating hormone (TSH) concentration, while central CH is characterized by a low T4 concentration and a normal, decreased, or slightly elevated TSH concentration ( 1 ). The Dutch newborn screening (NBS
Search for other papers by Kevin Stroek in
Google Scholar
PubMed
Endocrine Laboratory, Department of Clinical Chemistry, Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands
Search for other papers by Annemieke C. Heijboer in
Google Scholar
PubMed
Search for other papers by Marja van Veen-Sijne in
Google Scholar
PubMed
Search for other papers by Annet M. Bosch in
Google Scholar
PubMed
Search for other papers by Catharina P.B. van der Ploeg in
Google Scholar
PubMed
Search for other papers by Nitash Zwaveling-Soonawala in
Google Scholar
PubMed
Search for other papers by Robert de Jonge in
Google Scholar
PubMed
Search for other papers by A.S. Paul van Trotsenburg in
Google Scholar
PubMed
Search for other papers by Anita Boelen in
Google Scholar
PubMed
is hypothalamic or pituitary dysfunction, named secondary or central CH (CH-C) [ 1 ]. Early detection and treatment of CH prevent neurodevelopmental disabilities. Therefore, CH has been included in many newborn screening (NBS) programs worldwide since
Search for other papers by Zohar Steinberg Ben-Zeev in
Google Scholar
PubMed
Search for other papers by Marina Peniakov in
Google Scholar
PubMed
Search for other papers by Clari Felszer in
Google Scholar
PubMed
Search for other papers by Scott A Weiner in
Google Scholar
PubMed
Search for other papers by Avishay Lahad in
Google Scholar
PubMed
Search for other papers by Shlomo Almashanu in
Google Scholar
PubMed
The Rappaport Faculty of Medicine, Technion, Institute of Technology, Haifa, Israel
Search for other papers by Yardena Tenenbaum Rakover in
Google Scholar
PubMed
recommendation of maintaining TSH values in pregnant women below 2.5 mU/L ( 15 , 16 ). In most Western countries, newborn thyroid screening is standard, and its main purpose is to identify and initiate early supplemental thyroxine (T4) therapy in infants with
Search for other papers by Paolo Cavarzere in
Google Scholar
PubMed
Search for other papers by Laura Palma in
Google Scholar
PubMed
Search for other papers by Lara Nicolussi Principe in
Google Scholar
PubMed
Regional Center for Newborn Screening, Diagnosis and Treatment of Congenital Metabolic and Endocrinological Diseases, Verona, Italy
Search for other papers by Monica Vincenzi in
Google Scholar
PubMed
Search for other papers by Silvana Lauriola in
Google Scholar
PubMed
Pediatric Section, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy
Search for other papers by Rossella Gaudino in
Google Scholar
PubMed
Search for other papers by Virginia Murri in
Google Scholar
PubMed
Search for other papers by Luigi Lubrano in
Google Scholar
PubMed
Search for other papers by Giuliana Rossi in
Google Scholar
PubMed
Search for other papers by Alessia Sallemi in
Google Scholar
PubMed
Search for other papers by Ermanna Fattori in
Google Scholar
PubMed
Regional Center for Newborn Screening, Diagnosis and Treatment of Congenital Metabolic and Endocrinological Diseases, Verona, Italy
Search for other papers by Marta Camilot in
Google Scholar
PubMed
Pediatric Section, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy
Regional Center for the Diagnosis and Treatment of Children and Adolescents Rare Skeletal Disorders, Pediatric Clinic, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy
Search for other papers by Franco Antoniazzi in
Google Scholar
PubMed
treatment lead to a false negative newborn screening result for CH, delaying the necessary replacement therapy? In particular, to avoid the latest, some authors have suggested to perform serum thyroid function tests between 15 and 30 days of life in all
Pediatric Department B, Ha’Emek Medical Center, Afula, Israel
Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
Search for other papers by Tal Almagor in
Google Scholar
PubMed
Search for other papers by Shoshana Rath in
Google Scholar
PubMed
Search for other papers by Dan Nachtigal in
Google Scholar
PubMed
Search for other papers by Zohara Sharroni in
Google Scholar
PubMed
Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
Search for other papers by Ghadir Elias-Assad in
Google Scholar
PubMed
Search for other papers by Ora Hess in
Google Scholar
PubMed
Search for other papers by Gilad Havazelet in
Google Scholar
PubMed
Search for other papers by Yoav Zehavi in
Google Scholar
PubMed
Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
Search for other papers by Ronen Spiegel in
Google Scholar
PubMed
GGA – Galil Genetic Analysis Laboratory Ltd., Kazerin, Israel
Search for other papers by Dani Bercovich in
Google Scholar
PubMed
Search for other papers by Shlomo Almashanu in
Google Scholar
PubMed
Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
Search for other papers by Yardena Tenenbaum-Rakover in
Google Scholar
PubMed
at the Pediatric Endocrinology Institute, Ha’Emek Medical Center. The diagnosis of CH was based on abnormal thyroid function at birth; most patients were identified by the National Thyroid Newborn Screening Program. The etiology of the CH was
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Hospital de Braga, Braga, Portugal
Search for other papers by Maria Lopes-Pereira in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Search for other papers by Anna Quialheiro in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Search for other papers by Patrício Costa in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Search for other papers by Susana Roque in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
ACMP5 – Associação Centro de Medicina P5 (P5), School of Medicine, University of Minho, Braga, Portugal
Search for other papers by Nadine Correia Santos in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Search for other papers by Margarida Correia-Neves in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Search for other papers by Ana Goios in
Google Scholar
PubMed
Search for other papers by Ivone Carvalho in
Google Scholar
PubMed
Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands
The Generation R Study Group, Erasmus MC, University Medical Center, Rotterdam, the Netherlands
Search for other papers by Tim I M Korevaar in
Google Scholar
PubMed
Search for other papers by Laura Vilarinho in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Clinical Academic Center-Braga (2CA-B), Braga, Portugal
Search for other papers by Joana Almeida Palha in
Google Scholar
PubMed
/vaginal delivery/instrumental delivery), Apgar score and newborn birth weight, length and cephalic perimeter. Newborn TSH levels, between 3rd and 6th day of life, were obtained from the National Neonatal Screening Programme; normal values were considered if <10 mU
Search for other papers by Shirley Langham in
Google Scholar
PubMed
Search for other papers by Peter Hindmarsh in
Google Scholar
PubMed
Search for other papers by Steven Krywawych in
Google Scholar
PubMed
Developmental Endocrinology Research Group, Institute of Child Health, University College London, London, UK
Search for other papers by Catherine Peters in
Google Scholar
PubMed
Introduction The newborn screening programme for CH was introduced in the UK in 1981 [ 1 , 2 ] and has virtually abolished cases of untreated congenital hypothyroidism (CH). CH is a common (1 in 3,000-4,000 live births) condition [ 3 , 4 ] in
Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Anita Boelen in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands
Search for other papers by Nitash Zwaveling-Soonawala in
Google Scholar
PubMed
Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Endocrine Laboratory, Department of Laboratory Medicine, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
Introduction Congenital hypothyroidism (CH) is an inborn disorder of the endocrine system with potentially severe health consequences for the affected individual and was the second disorder to be included in the national newborn screening (NBS
Search for other papers by Solène Castellnou in
Google Scholar
PubMed
Search for other papers by Patricia Bretones in
Google Scholar
PubMed
Search for other papers by Juliette Abeillon in
Google Scholar
PubMed
Search for other papers by Myriam Moret in
Google Scholar
PubMed
Search for other papers by Pauline Perrin in
Google Scholar
PubMed
Search for other papers by Karim Chikh in
Google Scholar
PubMed
Search for other papers by Véronique Raverot in
Google Scholar
PubMed
antibodies progressively disappear [ 3 ]. Newborn screening for hypothyroidism is recommended in numerous countries because of the severe neurologic prognosis of congenital hypothyroidism [ 4 ], which occurs in approximately 1/2,000–1/4,000 newborns [ 5
Search for other papers by Juan Bernal in
Google Scholar
PubMed
-deficient regions of Spain and promoted salt iodization. They also established the program for the screening of congenital hypothyroidism in newborns. Prof. Escobar remained active until 2007 when he retired at the age of 84. He is survived by his spouse, Prof